Sei Investments Co. trimmed its holdings in shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) by 12.5% in the third quarter, according to its most recent filing with the SEC. The firm owned 140,012 shares of the medical device company’s stock after selling 19,988 shares during the period. Sei Investments Co. owned approximately 0.32% of K2M Group worth $2,969,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of KTWO. TimesSquare Capital Management LLC lifted its stake in K2M Group by 31.5% in the second quarter. TimesSquare Capital Management LLC now owns 2,888,020 shares of the medical device company’s stock valued at $70,352,000 after buying an additional 691,000 shares in the last quarter. Prudential Financial Inc. acquired a new stake in shares of K2M Group in the second quarter valued at approximately $6,595,000. Artemis Investment Management LLP increased its holdings in shares of K2M Group by 255.4% in the second quarter. Artemis Investment Management LLP now owns 316,703 shares of the medical device company’s stock valued at $7,716,000 after purchasing an additional 227,582 shares during the last quarter. State Street Corp lifted its holdings in shares of K2M Group by 39.8% in the second quarter. State Street Corp now owns 713,257 shares of the medical device company’s stock worth $17,378,000 after acquiring an additional 203,067 shares during the last quarter. Finally, Sectoral Asset Management Inc lifted its holdings in shares of K2M Group by 22.9% in the second quarter. Sectoral Asset Management Inc now owns 1,028,219 shares of the medical device company’s stock worth $25,047,000 after acquiring an additional 191,699 shares during the last quarter. Institutional investors own 98.22% of the company’s stock.

A number of research firms have recently commented on KTWO. Cowen set a $28.00 target price on shares of K2M Group and gave the stock a “buy” rating in a report on Thursday, August 17th. William Blair reaffirmed an “outperform” rating on shares of K2M Group in a research note on Tuesday, October 10th. Piper Jaffray Companies reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of K2M Group in a research note on Tuesday, October 10th. JMP Securities restated an “outperform” rating and set a $25.00 price objective (down from $30.00) on shares of K2M Group in a research note on Tuesday, October 10th. Finally, Zacks Investment Research upgraded shares of K2M Group from a “hold” rating to a “buy” rating and set a $25.00 target price on the stock in a research note on Wednesday, October 4th. One analyst has rated the stock with a sell rating, one has issued a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $25.00.

Shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) opened at $19.66 on Friday. K2M Group Holdings, Inc. has a 12-month low of $17.23 and a 12-month high of $25.99. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.67 and a current ratio of 3.06.

K2M Group (NASDAQ:KTWO) last announced its quarterly earnings data on Wednesday, November 1st. The medical device company reported ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.01). K2M Group had a negative net margin of 16.22% and a negative return on equity of 16.02%. The business had revenue of $62.65 million for the quarter, compared to the consensus estimate of $62.69 million. During the same period in the prior year, the company earned ($0.19) EPS. K2M Group’s quarterly revenue was up 5.6% on a year-over-year basis. equities analysts predict that K2M Group Holdings, Inc. will post -0.86 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This report was first reported by Daily Political and is the property of of Daily Political. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2017/12/01/sei-investments-co-has-2-97-million-stake-in-k2m-group-holdings-inc-ktwo.html.

K2M Group Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Institutional Ownership by Quarter for K2M Group (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.